Stockscreener 앱 받기
27.50
4.65%
-1.34
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Why Anbio Biotechnology Shares Are Sliding Fast - TipRanks
Assessing Anbio Biotechnology (NNNN) Valuation After Sharp Swings And A Rich Price To Book Multiple - simplywall.st
Anbio Biotechnology Broadens Test Portfolio And Shifts Risk Profile - Sahm
Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio - Sahm
Anbio Biotechnology posts solid FY25 results, diversifies portfolio - MSN
Form 20-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] - ADVFN
Discovering US Undiscovered Gems for April 2026 - simplywall.st
Anbio Biotechnology (NNNN) files 20-F/A to mark well-known seasoned issuer - Stock Titan
Anbio Biotechnology (ANBF) Non Cash 74.1% Net Margin Fuels Fresh Debate On Earnings Quality - Sahm
Anbio Biotechnology | 3: Initial statement of beneficial ownership of securities- Hartzler Nancy - Moomoo
Anbio Biotechnology (NNNN) CEO Michael Lau identified as insider in Form 3 - Stock Titan
Anbio Biotechnology (NNNN) director XU CANY files initial Form 3 - Stock Titan
Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks
Super-voting control and post-COVID shift at Anbio Biotechnology (Nasdaq: NNNN) - Stock Titan
Anbio Biotechnology Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Exxon Mobil, Pepsico among market cap stock movers on Monday - Investing.com UK
Exxon Mobil, Pepsico among market cap stock movers on Monday By Investing.com - Investing.com Canada
Anbio Biotechnology (NNNN) Surges 11.6% Intraday – What’s Fueling the Volatility? - Bitget
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
Why Anbio Biotechnology Class A Shares Are Jumping - TipRanks
Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum - The Manila Times
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum on March 17, 2026 - geneonline.com
Aktis Oncology (AKTS) Stock Analysis Report | Financials & Insights - Benzinga Japan
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World
Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today
Anbio Biotechnology falls -5.8% - MSN
Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge
Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World
TechTarget (TTGT) to Release Earnings on Wednesday - Defense World
Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha
NNNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head to Head Contrast - Defense World
NNNN Technical Analysis & Stock Price Forecast - Intellectia AI
Anbio Biotechnology Outperforms Oncocyte in Financial Metrics - National Today
Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility in the Medical Instruments Sector - DirectorsTalk Interviews
Critical Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology Outperforms Oncocyte in Head-to-Head Review - National Today
Celestica Inc. (TSE:CLS) Receives Average Recommendation of “Strong Buy” from Analysts - Defense World
Comparing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) - Defense World
Financial Contrast: Oncocyte and Anbio Biotechnology - National Today
Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Reviewing Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX) - Defense World
Diane Lazzaris Sells 2,747 Shares of WESCO International (NYSE:WCC) Stock - Defense World
Anbio Biotechnology and Oncocyte Compared: Which Stock Reigns Supreme? - National Today
Anbio Biotechnology (NNNN) Stock Analysis: What Investors Should Know About This German IVD Innovator - DirectorsTalk Interviews
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) Critical Comparison - Defense World
Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline - TipRanks
Anbio Biotechnology (NNNN) names GGF CPA LTD as new independent auditor - Stock Titan
Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
IPO window reopens, med-tech class of 2025 gains 26% - bioworld.com
Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World
GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World
0.06%
1.84%
자본화:
|
볼륨(24시간):